Oncocyte Corp.
13F holders, Q2 2024 (June 30)2holders
0new positions
0sold out
$2.95avg. 13F price*
At the end of Q2 2024, 2 institutions reported holding Oncocyte Corp. in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holders were AWM Investment Company, Inc. ($3.2M) and Defender Capital, LLC. ($163K).
- Company
- Oncocyte Corp.
- CUSIP
- 68235C107
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 342,889 shares bought and 665 shares sold, net +342,224 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| AWM Investment Company, Inc. | 0.44% | Add +45.5% | 1,097,175 | $3.2M |
| Defender Capital, LLC. | 0.06% | Reduce -1.2% | 55,220 | $163K |
"% of holder's portfolio" is ONCOCYTE CORP's weight in each manager's 13F, not the share of Oncocyte Corp. the manager owns.